Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
33.00
-20.69
-62.70%
Share Warrants & Outstandings
Total Reserve
33.10
6.46
26.64
412.38%
Shareholder's Funds
45.42
39.46
5.96
15.10%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
0.38
2.00
526.32%
Secured Loans
2.38
0.15
2.23
1,486.67%
Unsecured Loans
0.00
0.23
-0.23
-100.00%
Deferred Tax Assets / Liabilities
-4.37
0.33
-4.70
-1,424.24%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.13
-0.01
-7.69%
Total Non-Current Liabilities
-1.87
0.84
-2.71
-322.62%
Current Liabilities
Trade Payables
5.59
17.76
-12.17
-68.52%
Other Current Liabilities
1.74
3.57
-1.83
-51.26%
Short Term Borrowings
5.02
10.21
-5.19
-50.83%
Short Term Provisions
0.01
0.08
-0.07
-87.50%
Total Current Liabilities
12.37
31.62
-19.25
-60.88%
Total Liabilities
55.92
71.91
-15.99
-22.24%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
10.98
16.20
147.54%
Less: Accumulated Depreciation
8.48
1.37
7.11
518.98%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
9.61
9.09
94.59%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
0.00
10.14
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.00
0.05
0.00%
Long Term Loans & Advances
2.12
0.17
1.95
1,147.06%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
31.01
12.41
18.60
149.88%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.22
23.24
-15.02
-64.63%
Sundry Debtors
13.54
34.95
-21.41
-61.26%
Cash and Bank
0.73
0.06
0.67
1,116.67%
Other Current Assets
0.41
0.00
0.41
0.00%
Short Term Loans and Advances
2.00
1.25
0.75
60.00%
Total Current Assets
24.91
59.50
-34.59
-58.13%
Net Current Assets (Including Current Investments)
12.54
27.88
-15.34
-55.02%
Total Current Assets Excluding Current Investments
24.91
59.50
-34.59
-58.13%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
55.92
71.91
-15.99
-22.24%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.40
10.59
-3.19
-30.12%
Book Value per share (adjusted)
7.38
11.42
-4.04
-35.38%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024






